Светлоклеточная аденокарцинома яичников (диагностика, лечение, факторы прогноза)
Диссертация
По литературным данным (О.К, Хмельницкий, 1994), частота смешанных эпителиальных опухолей яичников составляет около 10% всех эпителиальных опухолей яичников, по другим данным (А.Е. Колосов, JI.H. Мкртчян, 1986) смешанные опухоли эпителиального происхождения встречаются очень редко и еще реже диагностируются. Среди них преобладают двухкомпонентные формы и значительно реже определяются… Читать ещё >
Содержание
- ГЛАВА I. ОБЗОР ЛИТЕРАТУРЫ
- 1. 1. Общие вопросы
- 1. 2. Частота возникновения
- 1. 3. Факторы риска
- 1. 4. Особенности гистогенеза светлоклеточных опухолей яичников
- 1. 5. Роль молекулярно-генетических изменений в развитии светлоклеточного рака яичников
- 1. 6. Клиника и особенности клинического течения светлоклеточных новообразований яичников
- 1. 7. Морфологическая характеристика и особенности гистологического строения светлоклеточных новообразований яичников
- 1. 8. Диагностика светлоклеточного рака яичников
- 1. 9. Лечение светлоклеточных новообразований яичников
- 1. 10. Факторы прогноза светлоклеточных опухолей яичников
- ГЛАВА II. МАТЕРИАЛ И МЕТОДЫ
- ГЛАВА III. КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА БОЛЬНЫХ СВЕТЛОКЛЕТОЧНЫМ РАКОМ ЯИЧНИКОВ И СМЕШАННЫМИ ЗЛОКАЧЕСТВЕННЫМИ ЭПИТЕЛИАЛЬНЫМИ ОПУХОЛЯМИ ЯИЧНИКОВ СО СВЕТЛОКЛЕТОЧНЫМ КОМПОНЕНТОМ
- 3. 1. Акушерско-гинекологический анамнез
- 3. 2. Распространенность заболевания
- ГЛАВА IV. ПАТОМОРФОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА СВЕТЛОКЛЕТОЧНЫХ АДЕНОКАРЦИНОМ ЯИЧНИКОВ И СМЕШАННЫХ ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ ЯИЧНИКОВ СО
- СВЕТЛОКЛЕТОЧНЫМ КОМПОНЕНТОМ
- ГЛАВА V. АНАЛИЗ ВЫЖИВАЕМОСТИ БОЛЬНЫХ И ФАКТОРЫ ПРОГНОЗА СВЕТЛОКЛЕТОЧНОГО РАКА ЯИЧНИКОВ И СМЕШАННЫХ ОПУХОЛЕЙ ЯИЧНИКОВ СО СВЕТЛОКЛЕТОЧНЫМ КОМПОНЕНТОМ
Список литературы
- Блюменберг А.Г. Диссеминированные формы рака яичников (лечение, факторы прогноза). Дисс.:докт.мед.наук. М., 2002. с. 36.
- Жорданиа К.И. Оптимизация диагностики и лечения рака яичников — Дисс. докт.мед.наук. — М.-1992. 153с.
- Жорданиа К.И. Злокачественные новообразования яичников, энциклопедия клин.онкологиии. М., 2004.С.
- Короленкова Л.И. Светлоклеточные (мезонефроидные) опухоли женских половых органов. Дисс. канд.мед.наук. М., 1983- с. 58.
- Сергеева Н.С., Ермошина Н. В. Использование опухолеассоциированных маркеров для диагностики и контроля за эффективностью терапии у больных распространенным раком яичников. Пособие для врачей., М. 2002, с. 9.
- Трапезников Н.Н., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ (состояние онкологической помощи, заболеваемость и смертность). М., 2001, с.95−96.
- Чекалова М.А. Ультразвуковая диагностика рака яичников., Сборник статей. Современные эксперементальные и клинические подходы к диагностике и рациональному лечению рака яичников. М, 2001- с. 53.
- Чекалова М.А., Зуев В. М. Ультразвуковая диагностика в онкогинекологии. М, 2004- с. 68.
- Alexander WK, Charles VB, William RH: Ovarian clear cell adenocarcinoma. Gynecol Oncol 32: 342 — 349, 1989.
- O.Anderson M.C., Langley F.A., Mesonephroid tumours of the ovary. J. Clin.Pathol. 1970- 23: 210−8.
- Aure JC, Hoeg K, Kolstad P. Mesonephroid tumors of the ovary: clinical and histopathologic studies. Obstet Cynecol 1971- 37:860 -7.
- Behbakht K, Randall TC, Benjamin I et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynec Oncol 1998−70(20):255−258.
- Benedetti Panici P, De Vivo A, Bellati F, Manci N, Perniola G, Basile S, Muzii L, Angioli R. Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 2006 Sep-41(9): 588−91.
- Bese Т., Kosebay D., Kalel S, et all. Appendectomy in the surgical staging of ovarian cancer. Gynecol. Oncol. 1996- 5:45−56.
- Chen S.M., Lee L. Incidence of paraaortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gyn Oncol 1983−16:95−100.
- Chew S, Tham KF, Ratnam SS. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis. Hum Pathol. 1997 Mar-28(3) :3 79−82.
- Choi HJ, Lee JH, Seok Lee J, Choi JI, Kang S, Lee S, Seo SS, Park SY. CT findings of clear cell carcinoma of the ovary. Gan To Kagaku Ryoho. 2006 0ct-33(10) .-1497−1500.
- Crotzer DR, Sun CC, Coleman RL, Wolf JK, Levenback CF, Gershenson DM. Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary. Mol Cancer Ther. 2007 Jan-6(l) :227−35. Epub 2007 Jan 11.
- Cuesta RS, Eichhorn JH, Rice LW, Fuller AF, Nikrui N, Goff BA: Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol 60: 238 — 244, 1996.
- Czernoblisky В., Silverman B.B., and Enterline H.T. Clear cell carcinoma of the ovary. A clinicopathological analysis of pure and mixed forms and comparison with endometrioid carcinoma, Cancer 1970−25: 762−772.
- Deguchi M, Matsumoto Y, Ishiko O, Ogita S. Angiogenesis in ovarian clear cell carcinoma and its relation to endometriosis. Oncol. Rep. 2000 May-Jun-7(3) :651−4.
- Dent J, Hall GD, Wilkinson N, Perren TJ, Richmond I, Markham AF, Murphy H, Bell SM. Cytogenetic alteration in ovarian clear cell carcinoma detected by comparative genomic hybridization. Br J Cancer.2003 May 19−88(10):1578−83
- Diagn Citopathol. 2001 May-24(5): p.328−32.
- Dimitrios Pectasides, Eirini Pectasides, Amanda Psyrri and Theofanis Economopoulos. Treatment IssuesOncologist 2006- 11- 1089−1094.
- Doshi N., Tobon H. Primary clear cell carcinoma of the ovary. Cancer 1977,39−2658−2666.
- Eastwood G. Mesonephroid (clear cell) carcinoma of the ovary and endometrium. Cancer (Philad), 1978−41:1911−1928.
- Eric L. Jenison., Anthony G. Montag, C. Thomas Griffiths, William R. Welch, et all. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol. Oncol. 1989−32:65−71.
- Ferenczy A. The ultrastructural morphology of gynecologic neoplasms. Cancer, 1976- 38 1 suppl. 463−486.
- Fine G., Clarke H., Horn R. Mesonephroma of the ovary. Cancer, 1973,31- 398 410.
- Fujimura M, HidakaT, Saito S. Selective inhibition of the epidermal growth factor receptor by ZD 1839 decreases the growth and invasion of ovarian clear cell adenocarcinoma cells. Onclogy, 2002- 32(2): 180−4.
- Fujwara K., Maehata K., Kohno I., Yoden E., Imajo Y., Mikami Y. A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy. Gan To Kadaku Ryoho.2000 Dec: 27(14) :2259−62.
- Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1998 Feb-32(2) :182.
- Hameed K, Burslem MR, Tupper WR. Clear cell carcinoma of the ovary. Cancer 1969−24:452−459.
- Hameed, K, Burslem, M.R.G., and Tupper, G.W.R. Clear cell carcinoma of the ovary. Cancer 24, 452 (1969).
- Hayes D. Mesonephroid tumours of the ovary. J.Gynecol. Brit. Commonw.79,728(1972).
- Hart W.R. and Norris H.J. Mesonephric adenocarcinomas of the cervix. Cancer 29:106−113, 1972.
- Hreshchyshyn M.M., Park R.C., Blessing J.A., et all. The role of adjuvant therapy in stage I ovarian cancer. Am J Obstet Gynecol 1980−138:139−145.
- Jenison EL, Montag AG, Griffiths CT et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol, Oncol 1989−32:65−71.
- Jennings TS, Haddad ME, Smith TM. Clear Cell Ovarian Carcinoma Followimg Long-Term Tamoxifen Use. Am J Surg Pathol. 2001 May-25(5) :667−72.
- Kaku S, Hirai Y, Fujimoto Z, Nakayama K, Chen JT, Shimizu Y, Hamada T, Yamauchi K, Hasumi K, Masubuchi K. Clinicopathological study on clear cell cfrcinoma of the ovary. Nippon Sanka Fujinka Gakkai Zasshi 1989 Jul-41(7) :875−80.
- Kawagishi N, Shirahata Y, Ishida K, Enomoto Y, Akamatsu Y, Sekiguchi S, Fukumori T, Fujimori K, Satoh A, Moriva T, Satomi S. Hepatic resection of giant metastatic tumor clear cell carcinoma of the overy. Int J Oncol. 2005 Jan-26(l):177−83.
- Kennedy A.W., Biscotti C.V., Hart W.R., Tuason L.J. Histologic correlates of progression-free interval and survival in ovarian clear cell adenocarcinoma. Gynecol. Oncol. 1993 Sep- 50(3): 334−8.
- Kennedy AW, Biscotti CV, Hart WR et al. Ovarian clear cell adenocarcinoma. Gynecol Oncol 1989−32:342−349.
- Kennedy AW, Markman M, BiscottiCV et al. Survival probability in ovarian clear cell adenocarcinoma. Gynecol Oncol 1999−74:108−114.
- Klemi P.J. and Gronroos M. Mesonephroid carcinoma of the ovary. A clinicopathologic, histochemical and electron microscopic study. Obstet. Gynecol., 1979−53/4:472−479.
- Klemi P. S., Meurman L, Gronroos. Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor. Int J Gynecol Pathol. 1982−1:95−100.
- Kurman RE, Graig JM: Endometrioid and clear cell carcinoma of the ovary. Cancer 20: 1653 — 1664, 1972.
- Lee R.A., Dockerty M.D., Wilson R.B., Symmonds R.E. Mesonephroma of the ovary. Am.J. Obstet Gynecol. 1962, 82−677−681.
- Makar AP, Baekelandt M, Trope CG, Kristensen GB. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 1995- 56: 175−8.
- Matsuoka У, Ohtomo К, Araki К, Kojima К, Yoshikawa W, Fuwa S. MR imaging of clear cell carcinoma of the ovary. Breast J. 1999 Mar-5(2): 132 135.
- Matsuura Y, Robertson G, Marsden DE, Kim SN, Gebski V, Hacker NF. Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol. 2006 Nov- 103(2) :740−4.
- Milewich L, Porter J. Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. J. Clin. Endocrinal. Metab. 1987. 1649.
- Monga M, Carmichael JA, Shelly WE: Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical staging. Gynecol Oncol 43: 195 -197, 1991.
- Montag AG., Jenison EL, Griffiths CT, Welch WR, Lavin PT, Knapp RC. Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 casis. Int J Gynecol Pathol 1989- 8 (2) :85−96.
- Nakano T, Enoki K, Nakashima H, Ametani Y, Ohta S, Ohkuchi A, Satake S, Kojima Y, Funamoto H, Tateno M, Miwa A. Survival in patients with clear cell carcinoma of the ovary. Gan To Kagaku Ryoho 1998 Jan-25(l) :67−73.
- Nakashima N, Nagasaka T, Fukata S, et al. Study of ovarian tumors treated at Nagoya University Hospital 1965−1988. Gynecol Oncol. 1990−37:103−111.
- Nishida M, Tsunoda H, Ichikawa Y, Yoshikawa H. Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma. Clin Cancer Res. 2004 Nov 1- 10(21) :7418−26.
- Nishino K., Aoki Y., Amikura T et all. Irinotecan hydrochloride (CPT-11) and mitomycin С as the first line chemotherapy for ovarian clear cell adenocarcinoma. Gynecol. Oncol 2005−97:893−897.
- Nolan LP, Heatley MK. The value of immunocytochemistry in olistinguishing between clear cell carcinoma of the ovary and kidney. Int J Gynecol Pathol. 2001 Apr-20(2): 155−9.
- Norris H.J., Robinowitz M. Ovarian adenocarcinoma of mesonephric type. Cancer, 1972−28:1074−1081.
- Parker J, Proietto A.M., Lowe G. Clear-cell carcinoma of the ovary in a 19-year-old woman. Semin Diagn Pathol. 1997 Now- 14(4): 233−9.
- Parker T.M., Dockerty M.B., Randall L.M. Mesonephric clear cell carcinoma of the ovary. Am.J. Obstet. Gynec., 1960−80:417−425.
- Parther S, Quinn MA. Clear cell cancer of the ovary-is it chemosensitive. Dyagn Cytopathol. 2005 Jun-32(6) :336−340.
- Pather S, Quinn MA. Clear cell cancer of the ovary-is it chemosensitive? Int J Gynecol Cancer 2005−15:432−437.
- Peham H. Aus accessorischen Nebennieren-Anlage entstandene Ovarial-Tumore. Monatschr. Geburtsch. 10,685 (1899).
- Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm, International Federation of Gynecology and Obstetrics, 1991.
- Russell P., Merkur H. Proliferating ovarian epithelial tumors: a clinicopathological analisis of 144 cases. Aust N Z J Obstet Gynecol 1979- 19: 45−51.
- Russell P: Surface epithelial — stromal tumor of the ovary, in Kurman RJ (eds): blausteins pathology of the female genital tract, 4th ed, Springer-Verlag, New York, 1995, pp 752−762.
- Russel P. The pathological assessment of ovarian neoplasms: introduction to the common epithelial tumours and analysis of benign epithelial tumours. Pathology 1979- 11:5−26.
- Recio FO, Piver MS, Hempling RE et al. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 1996−78:2157−2163.
- Rogers L.W., Julian C.G., Woodruff J.D. Mesonephroid carcinoma of the ovary. A study of 95 cases from the Emil Novak ovarian tumour registry. Gynecol. Oncol. 1972- 1:76−89.
- Rorat E., Ferenczy A., Richart R.M. The ultrastructure of clear cell carcinoma of endometrium. Cancer- 1974−33:880−887.
- Roth L.M., Langley F.A., Fox H., wheeler J.E., Czemobilsky B. Ovarian clear cell adenocarcinomatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma. Cancer 1984- 53: 1156−63.
- Rustin G.J.S., van der Burg M.E.L., Berek J.S. Tumor markers. Ann Oncol., 1993−4(suppl) :71−77.
- Saga Y, Suzuki M, Machida S, Ohwada M, Sato I. Establishment of a new cell line (TAYA) of clear cell adenocarcinoma of the ovary and its radiosensitivity. Int J Gynecol Cancer, 2002 Jan-Feb-12(l): 124−7.
- Sugiyama Т., Kamura Т., Kigawa J. et all. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 2000−88:2584−2589.
- Salazar H., Merkow L.P., Walter W.S., Pardo M. Human ovarian neoplasms: light and electron microscopic correlations.il. The clear cell tumor. Obstet and Gynecol.- 1974: 44, .4: 551−563.
- Saphir, 0., and Lackner, J. Adenocarcinoma with clear cells (hypernephroid) of the ovary, Surg. Gynecol. Obstet. 79, 539 (1944).
- Schiller W. Mesonephroma ovarii, Amer J. Cancer 35, 1(1939).
- Schiller W. Parvilocular cystomas of the ovary. Arch Pathol 1943−35:391−413.
- Scully RE and Barlow JF. «Mesonephroma» of ovary. Tumor of Mullerian nature related to the endometrioid carcinoma. Cancer 20,1405 (1967).
- Scully RE. mesonephroma of the ovary: clinicopathology characteristics. Cancer 35: 1206 — 1214, 1963
- Scully R.E., Sobin L.H. Histological typing of ovarian tumours. 2nd ed. Worid Health Organization international histological classification of tumours. Berlin: Springer-Verlag, 1999.
- Scully R.E. Ovary. In: Henson D.E., Albores-Saavedra J, eds. The pathology of incipient neoplasia. Philadelphia: WB Saunders, 1993: 283−300.
- Scully R.E., Young R.H., Clement P.B. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. IN: Atlas of tumor pathology. 3nd series. Fascicle 23 (3F23). Washington, DS: Armed Forces Institute of Pathology, 1998: pp. 140−151.
- Scully R.E. Recent progress in ovarian cancer. Human Pathology- 1970−1:7398.
- Scully R.E. Ovarian tumors. J. Pathol. 1977−87:686.
- Serov S.F., Scully R.E., and Sobin L.H. Histological typing of ovarian tumours, in International histological classification of tumours, 9, WHO, Geneva, pp. 37−42 (1973).
- Shevchuk M.M., Winkler-Monsanto В., Fenoglio C.M. et al. Clear cell carcinoma of the ovary a clinicopathologic study with review of the literature. Cancer 1981−47:1344−1351.
- Shimizu Y. Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma. Gan To Kagaku Ryoho- 24 Suppl 1:61−9 1997.
- Shumizu Y, Umezawa S, Utsugi K, Hasumi K, Fujiwara K, Kohno I. Combination of CPT — 11 with mitomycin — с (MMC) for platinum — refractory clear cell and mucinous adenocarcinoma of the ovary abstract 1393. Proc Am Soc Clin Oncol 1999- 18: 361a.
- Shiromizu K., Sugase M., Kawana T. et all. Clinicopathologic study of mesonephric adenocarcinoma. J. Jap. Soc. Cancer Ther., 1977−9:271.
- Silverberg S.G. Ultrastructure and histogenesis of clear cell carcinoma of the ovary. Am. J. Obstet. Gynecol., 1973- 115:394−400.
- Skirnisdottir I, Seidal Т, Karlsson MG et al. Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II. Int J Oncol 2005−26:177−183.
- Swisher E.M., Mutch D.G., Rader J. S: Topotecan in platinum- and paclitaxel-resistant ovarian cancer. Gynecol Oncol 66:480−486, 1997.
- Suwaki N, Masuyama Y, Kodama J, Hiramatsu Y. Parathyrroid hormone-related protein as a potential tumor marker: a case report of ovarian clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2006 Jul- 127(1): 130−6 Epub 2006 Jan 27.
- Suzuki M, Saga Y, Tsukagoshi S, Tamura N, Sato I. Recurrent ovarian clear cell carcinoma: complete remission after radiation in combination with hyperthermia- a case study and in vitro study. Gan To Kagaku Ryoho. 2000 Dec-27(14) :2259−62.
- Takeuchi S., Dobashi K., Fujimoto S: A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Jpn J Cancer Chemother 18:16 811 689, 1991.
- Telium G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so called mesonephroma ovarii (Shiller) and extraembronic (yolk sac-allantoic) structures of the rats placenta. Cancer, 1959- 12:1092−1105.
- Torn Sugiyama, Toshiharu Kamura, Junzo Kigawa, Naoki Terakawa, Yoshihiro Kikuchi, Tunekazu Kita, Mitsuaki Suzuki, Ikuo Sato, Kouji Taguchi. Clinical Characteristics of Clear Cell Carcinoma of the Ovary. Cancer, Jun. 2000- 11 2584−88.
- Tsuda H., Bandera C.A., Birrer M.J. et all. Ciclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology 2004- 67: 291−299.
- Van Kirk, F.W., Jr., and Edwards, E.A. Hypernephroma of the ovary, Amer J. Cancer 37, 209(1939).
- Vercellini P, Parazzini F, Bolis G, Carinelli S, Dindelli M, Vendola N, Luchini L, Crosignani PG: Endometriosis and ovarian cancer. Am J Obstet Gynecol 169: 181 — 182, 1993.
- Yoonessi M, Weldon D, Satchidand SK et al. Clear cell ovarian adenocarcinoma. J. Sureg Oncol 1984−27:289−297.
- Young R.H., Clement Ph.B., Scully R. E «The ovaiy"chapter 49 in «Diagnostic Surg. Pathol.» — 1989.-Vol.2.-pl681−1684.
- Young RH, Scully RE. Oxyphilic clear cell carcinoma of the ovary .A report of nine cases. Am J Surg Pathol 1987: Sep- 11 (9) :661−7.
- Wade-Evans Т. and Langley F.A. Mesonephric tumors of the female genital tract — Cancer-1961- 14: 711 -724.
- Zhang G.N., Yu S., Xigo Q. The clinical role of appendectomy in surgical procedures for ovarian cancer. Chung Hua Fu Chan Ко Tsa Chin- 1994, 29(11): 662−3.
- Zirker T.A., Silva E.G., Morris M, Ordonez N.G. Immunohistochemical differentiation of clear cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alphafetoprotein and Leu-Mi. Am J Clin Pathol 1989,91:511−4.